Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Biocon Biologics Inc.

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
REGENERON PHARMACEUTICALS, INC.,
Plaintiff-Appellee
v.
MYLAN PHARMACEUTICALS INC., BIOCON
BIOLOGICS INC.,
Defendants-Appellants
AMGEN USA, INC., CELLTRION, INC., SAMSUNG
BIOEPIS CO., LTD., FORMYCON AG, AMGEN INC.,
Defendants
______________________
2024-2002
______________________
Appeal from the United States District Court for the
Northern District of West Virginia in Nos. 1:22-cv-00061-
TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-
JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM,
1:24-cv-00039-TSK-JPM, 1:24-cv-00053-TSK, 1:24-md-
03103-TSK-JPM, Chief Judge Thomas S. Kleeh.
______________________
O R D E R
The parties, having so agreed,
I T I S O RDERED T HAT :
Case: 24-2002 Document: 59 Page: 1 Filed: 04/16/2025

-- 1 of 2 --

REGENERON PHARMACEUTICALS, INC. v. MYLAN
PHARMACEUTICALS INC.
2
The above-captioned appeal is dismissed under Fed. R.
App. P. 42(b) with each side to bear their own costs.
April 16, 2025
Date
F OR THE COURT
ISSUED AS A MANDATE: April 16, 2025
Case: 24-2002 Document: 59 Page: 2 Filed: 04/16/2025

-- 2 of 2 --